Weight loss drug maker sinks 25% after new safety data spooks investors

Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data on its experimental medicine raised concerns over its potential side effects. The Danish drugmaker said that while its drug survodutide met its key targets in a late-stage study, 19% of patients dropped out of the study due [...] The post Weight loss drug maker sinks 25% after new safety data spooks investors appeared first on NYT News Today .
2026-06-08 09:40:00